clinical topic updates

Should Multiple Mantle Cell Lymphoma Therapies Be Given in Sequence or in Combination?
Oncology

Should Multiple Mantle Cell Lymphoma Therapies Be Given in Sequence or in Combination?

clinical topic updates
By Julie M. Vose, MD, MBA, FASCO
Treatment Recommendations for Durable Count Control in Polycythemia Vera
Oncology

Treatment Recommendations for Durable Count Control in Polycythemia Vera

clinical topic updates
By Ruben A. Mesa, MD, FACP
Traditional and Nontraditional Risk Factors in Patients With Myeloproliferative Neoplasms
Oncology

Traditional and Nontraditional Risk Factors in Patients With Myeloproliferative Neoplasms

clinical topic updates
By Rami S. Komrokji, MD
MAPK Pathway Mutations Mediate Primary Resistance to PI3K Inhibition in Chronic Lymphocytic Leukemia
Oncology

MAPK Pathway Mutations Mediate Primary Resistance to PI3K Inhibition in Chronic Lymphocytic Leukemia

clinical topic updates
By Jennifer R. Brown, MD, PhD
Potential Usefulness of Dual B-Cell Receptor and PARP Inhibition in Relapsed del(11q) Chronic Lymphocytic Leukemia
Oncology

Potential Usefulness of Dual B-Cell Receptor and PARP Inhibition in Relapsed del(11q) Chronic Lymphocytic Leukemia

clinical topic updates
By Jennifer R. Brown, MD, PhD
Load More